1. P1202: INTENDED USE OF GLUCARPIDASE IN PATIENTS WITH CENTRAL NERVOUS SYSTEM LYMPHOMA AND IMPAIRED RENAL FUNCTION – THE VALIDATE STUDY. (23rd June 2022) Authors: Liebig, S.; Burock, S.; Merz, I.; Knörnschild, F.; Kießling, P.; Kappert, K.; Keller, U.; Schwartz, S. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1088 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Senescence mirrors the extent of liver fibrosis in chronic hepatitis C virus infection. Issue 3 (4th June 2018) Authors: Wandrer, F.; Han, B.; Liebig, S.; Schlue, J.; Manns, M. P.; Schulze‐Osthoff, K.; Bantel, H. Journal: Alimentary pharmacology & therapeutics Issue: Volume 48:Issue 3(2018) Page Start: 270 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗